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Abstract: Production of IL-12 and IFN- secretion are important components of the protective host response against the 
intracellular bacterial pathogen, Salmonella typhimurium. While infection with Salmonella does elicit this T helper type 1 
response, its magnitude does not appear to be sufficient to prevent infection or limit pathogenesis. Therefore we have  
investigated factors which might limit a T helper type 1 response following infection. Previously we found that infection 
of antigen presenting cells with Salmonella dramatically increases cyclooxygenase-2 (COX-2) activity, resulting in high 
levels of prostaglandin E2 (PGE2). Since PGE2 production can have profound effects on initiation of T helper type 1  
responses, we questioned whether this mediator might limit antigen-specific T cell activation. Here we show that blockage 
of COX-2 activity with the selective inhibitor celecoxib leads to enhancement of the T helper type 1 components   
stimulated by Salmonella infection. In vitro studies demonstrate the induction of IL-12 and IFN- upon Salmonella  
exposure, which are further increased following COX-2 inhibition. Taken together these in vitro studies suggest that 
COX-2 activity can limit a salmonella-initiated T helper type 1 response.  
INTRODUCTION 
  Oral inoculation of susceptible mice with Salmonella 
typhimurium results in a disease state similar to human   
typhoid fever and serves as a useful model for intracellular 
bacterial infection. During infection of the intestinal mucosa, 
Salmonella organisms invade and then survive and grow 
within resident macrophages and dendritic cells [1, 2]. If the 
inoculum is sufficient, a lethal, systemic disease ensues. 
Salmonella’s capacity for intracellular survival makes the 
initiation of an effective cell-mediated immune response 
crucial for survival of the host [3-6]. Fundamental to this 
response is the activation of macrophages and dendritic cells 
to produce IL-12 p70, eliciting IFN- production from CD4+ 
T cells, which further enables infected cells to kill the   
pathogens they harbor [7, 8]. The requirement for cellular 
immunity is observed in humans with genetic defects in IL-
12 receptor [3, 9] or IFN- receptor [7] signaling, who   
frequently present with recurrent Salmonella infections.   
In the animal model, deletion or antagonism of IL-12 [6]   
or IFN- [10, 11] increases susceptibility to salmonellosis,  
further supporting the importance of these components in 
resolving infection. While these cytokines are certainly   
produced in response to infection [6, 12], the fact that in vivo 
treatment of mice with recombinant IL-12 augments protec-
tion [13] suggests that endogenous IL-12 production may   
be less than optimal. 
  Although the presence of IL-12 at the time of T cell   
activation facilitates the development of the T helper cell 
response, it has been suggested that another player, PGE2, 
can influence this process. Specifically, the ratio of IL-12 to  
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PGE2 is the limiting factor in initiation of IFN- production 
and commitment to a T helper type 1 lineage [14]. PGE2 has 
been shown to inhibit the secretion of IL-12p70 from human 
monocytes and bone marrow derived dendritic cells, and 
selectively induces IL-12p40, an IL-12 antagonist [15-17]. 
There is also strong evidence for PGE2-mediated inhibition 
of the IL-12 receptor, diminishing IL-12 responsiveness 
[18]. Therefore the production of PGE2 in the environment 
of T cell activation has the potential to inhibit generation of a 
T helper type 1 mediated immune response. Additionally, 
resistance to re-infection requires the development of T 
helper type 1 immunological memory [19], and the IL-12 
signaling pathway is necessary for an effector memory   
response [9]. Carrier state, relapse and re-infection may   
occur in both S. typhimurium and S. typhi related etiologies 
[20], with the implication that the initial infection does not 
bring about lasting immunity. 
  Studies in our laboratory have shown that macrophages 
and dendritic cells are activated by Salmonella to secrete a 
significant amount of PGE2 [21]. This response occurs both 
in vitro and in vivo, is COX-2 dependent, and is generated to 
a greater extent by viable pathogens than by killed bacteria 
or LPS [21]. This suggests that Salmonella stimulates pro-
duction of conflicting mediators, and while this is a common 
theme in maintaining homeostasis, it may also be advanta-
geous to the pathogen. Because the initiation of an adaptive 
immune response within this context may be hindered, it was 
of interest to determine the extent to which an antigen spe-
cific T helper type 1 response is inhibited by this particular 
feature of Salmonella infection. In studies presented here, 
DO11.10 TCR transgenic animals were used as a source of 
CD4+ T cells, and their response to antigenic stimulation in 
the presence of infected macrophages and dendritic cells was 
assessed. The relative contributions of COX-2, contact, and 
IL-12 were evaluated using this in vitro model. 24    The Open Microbiology Journal, 2009, Volume 3  Bowman and Bost 
MATERIALS AND METHODOLOGY 
Isolation of Peritoneal Macrophages and Bone Marrow 
Derived Dendritic Cells 
  Peritoneal macrophages were isolated as previously   
described [22, 23]. Briefly, BALB/c mice were injected   
intraperitoneally with 250 μl of incomplete Freund’s   
adjuvant (Sigma Chemical Co., St Louis, MO). Four days 
later, the mice were euthanized, and peritoneal cavities were 
lavaged with RPMI-1640 (Gibco-BRL, Grand Island, NY) 
containing 2% FCS. Peritoneal cells were washed twice   
and then allowed to adhere to 12-well tissue culture plates 
(Costar, Cambridge, MA) for 45 minutes in RPMI-1640   
containing 10% FCS before washing to remove non-adherent 
cells. 
  Bone marrow derived dendritic cells were isolated as 
previously described [24]. Briefly, femurs were flushed with 
RPMI-1640 containing 2% FCS to collect total bone marrow 
cells. Spicules and bone matrix were allowed to settle and 
removed. Total bone marrow cells were washed once and re-
suspended in RPMI-1640 containing 12% FCS and 1000 
U/ml GM-CSF (PharMingen, San Diego, CA). Cells were 
fed every three days by adding 50% fresh medium. After 7 
days in culture, non-adherent cells were removed, washed, 
and aliquoted into tissue culture plates in RPMI-1640 10% 
FCS without antibiotics, and exposed to medium or wild 
type Salmonella as described below.  
  All experiments using these animals were conducted fol-
lowing the guidelines set forth by the University of North 
Carolina at Charlotte Institutional Animal Care and Use 
Committee.  
In Vitro Exposure of Macrophages or Dendritic Cells to 
Salmonella 
  Macrophages or dendritic cells cultured in RPMI-1640 
10% FCS without antibiotics were briefly exposed to live 
Salmonella at ratios of 3:1 or 10:1 bacteria to cells. After 45 
minutes, extracellular bacteria were removed by washing the 
cells and by the addition of gentamicin-containing medium. 
Culture supernatants were isolated from the cultures at the 
indicated times post-infection for PGE2, IFN-, or IL-4 
analyses, respectively. In addition, some cells were treated 
with 1μM celecoxib (Pharmacia Corporation, Peapack, NJ) 
for 20 minutes prior to the addition of bacteria. 
Stimulation of CD4+ T Cells 
  Spleens were harvested from euthanized BALB/c   
or DO11.10 TCR transgenic mice (The Jackson Laboratory, 
Bar Harbor, ME). Single cell suspensions were prepared by 
passage through a stainless steel sieve followed by lysis of 
red blood cells. CD4+ T cells were isolated with anti-mouse 
CD4 (L3T4) conjugated beads according to manufacturers’ 
instructions (Miltenyi, Auburn, CA). B lymphocytes were 
isolated from BALB/c splenocyte suspensions with anti-
B220 conjugated beads (Miltenyi). DO11.10 CD4+ cells 
were cultured with equal numbers of BALB/c B cells as   
antigen presenting cells and stimulated with 1 μg/ml OVA 
peptide (OVA323-339) (Research Genetics, Huntsville, AL). 
CD4+ T cells from BALB/c animals were stimulated with 50 
pg/ml recombinant IL-12p70 (PharMingen). Transwell   
cultures were performed in 12-well plates using 12 mm 
diameter polycarbonate membranes with 0.4 μm pores 
ameter polycarbonate membranes with 0.4 μm pores (Costar, 
Corning, NY). Anti IL-12 or isotype control antibodies 
(PharMingen) were used at a final concentration of 2 μg/ml. 
Quantitation of PGE2 in Culture Supernatants 
 PGE2 levels in culture supernatants were analyzed using 
the Prostaglandin E2 Direct Biotrak Assay (Amersham 
Pharmacia Biotech, Piscataway, NJ), according to instruc-
tions from the manufacturer as previously described [21]. 
Quantitation of Cytokines in Culture Supernatants and 
Tissue Homogenates 
  Culture supernatants were assayed for IFN- or IL-12p70 
by ELISA using the appropriate
 capture and detection anti-
body pairs and recombinant standards (PharMingen). 
Statistical Analyses 
  Statistical analyses were performed using ANOVA 
analyses (Graphpad Software, Inc., San Diego, CA). 
RESULTS 
PGE2 Production is Stimulated by Infection of Elicited 
Peritoneal Macrophages with Salmonella Typhimurium 
  Previous studies in our laboratory have demonstrated that 
macrophages and dendritic cells respond to Salmonella in-
fection with a robust inflammatory response, producing large 
amounts of PGE2 [21] This response has been shown to be 
dependent on COX-2 activity, since it is entirely abrogated 
by the introduction of the COX-2 specific inhibitor cele-
coxib. The amount of PGE2 secreted during an encounter 
with viable bacteria is far greater than that produced upon 
exposure to LPS or UV-killed Salmonella. These same cell 
types are responsible for PGE2 production in the mesenteric 
lymph nodes after oral inoculation with Salmonella [21]. 
Therefore PGE2 is present in the microenvironment of im-
mune induction and may influence the initiation of an anti-
gen-specific response. In order to examine the pattern of 
PGE2 production in the context of antigen-specific T cell 
priming during Salmonella infection, mixed cultures of 
DO11.10 CD4+ T cells, B cells, and elicited peritoneal 
macrophages or bone marrow-derived dendritic cells were 
prepared and stimulated with the Ova peptide antigen. 
  The results of one such experiment are shown in Fig. (1). 
Resting macrophages produced a low background level of 
PGE2, most likely as a result of constitutive expression of 
COX-1 (Fig. 1A). Culture supernatants from T and B cells 
contained only background levels of PGE2, even when anti-
gen was added (Fig. 1A). When macrophages were infected 
with Salmonella typhimurium at a multiplicity of infection of 
either 3:1 or 10:1, PGE2 secretion increased by more than an 
order of magnitude (Fig. 1B). The addition of 1 μM cele-
coxib inhibited this response, indicating that PGE2 increases 
were due to COX-2 activity (Fig. 1B).  
  The same experiments performed with dendritic cells 
yielded similar results. Resting dendritic cells produced 0.26 
ng/ml PGE2, versus 2.07 ng/ml when infected with Salmo-
nella at a ratio of 3:1. The addition of T and B cells raised 
levels to 0.40 ng/ml in uninfected cultures with no further 
increase upon addition of the Ova peptide. Infected cultures 
produced 3.0 ng/ml PGE2 when T and B cells were present, Celecoxib Treatment Augments Interferon Gamma In Vitro  The Open Microbiology Journal, 2009, Volume 3    25 
and levels increased significantly with addition of antigen to 




















Fig. (1). PGE2 production in mixed cultures of DO11.10 CD4+ T 
cells, B cells, and elicited peritoneal macrophages infected with 
Salmonella typhimurium. Peritoneal macrophages were isolated and 
cultured in the presence of medium alone (A) or viable Salmonella 
(B). The dose of bacteria initially added to each well was 3:1 (3) or 
10:1 (10) bacteria to macrophage, as indicated. Following exposure 
for 45 minutes, cells were washed to remove any extracellular bac-
teria with gentamicin-containing medium. Magnetically separated 
splenic DO11.10 CD4 + T cells, B cells, and OVA peptide were 
added. Some cultures were supplemented with 1 uM celecoxib 20 
minutes prior to infection. Culture supernatants were collected at 24 
hours post-infection and stored at -80°C .  L e v e l s  o f  P G E 2 were 
measured by enzyme immunoassay, and are reported as mean val-
ues of triplicate determinations. An asterisk indicates a statistically 
significant difference (p < 0.01) when compared to cultures without 
celecoxib. These studies were performed three times with similar 
results. 
Antigen-Driven IFN- Production by CD4+ T Cells is 
Stimulated by Infection of Cocultured Peritoneal Macro-
phages with Salmonella Typhimurium 
 IFN- production via Salmonella-infected macrophages 
was exhibited by mixed cultures of DO11.10 CD4+ T and B 
cells (Fig. 2A). IFN- levels were significantly elevated (p < 
0.05) by the combination of both antigen and the presence of 
infected macrophages when compared to similar mixed cul-
tures in the absence of antigen.  
  When the corresponding studies were performed using 
bone marrow derived dendritic cells, a similar pattern of 
IFN- secretion was observed (Fig. 2B). Among Ova stimu-
lated cultures, the amount of secreted IFN- was found to be 
significantly higher where dendritic cells had been exposed 
to Salmonella (p < 0.01). These results indicate that Salmo-
nella-infected dendritic cells, like macrophages, were able to 

























Fig. (2). Salmonella-infected macrophages augment IFN- produc-
tion by antigen-stimulated DO11.10 CD4+ T cells. Peritoneal 
macrophages were isolated and cultured in the presence of medium 
alone or viable Salmonella. Following exposure for 45 minutes, 
cells were washed to remove any extracellular bacteria with gen-
tamicin-containing medium. Magnetically separated DO11.10 CD4 
+ T cells, B cells, and OVA peptide were added as indicated (A). In 
other studies, bone marrow-derived dendritic cells were infected 
with  Salmonella and treated with gentamicin 45 minutes post-
infection and prior to addition of DO11.10 CD4 + T cells, B cells, 
and OVA peptide (B). Levels of IFN- were measured by enzyme 
immunoassay, and are reported as mean values of triplicate deter-
minations. These studies were performed three times with similar 
results. 
Contact Inhibition by Transwell Coculture and Anti-IL-
12 Each Partially Reduce the IFN- Response 
  In order to assess the individual contributions of contact 
and soluble factors to IFN- production, additional studies 
were performed with macrophages and DO11.10 CD4+ T 
and B cells. In Fig. (3A), macrophages were separated from 
T and B cells by transwell barriers. Cultures were stimulated 
with Ova peptide for 48 hours, at which time supernatants 
were collected and assayed for levels of IFN-. Prevention of 
physical contact between macrophages and T cells reduced 
the amount of IFN- produced by less than half, indicating 26    The Open Microbiology Journal, 2009, Volume 3  Bowman and Bost 
that while some of this response is contact dependent, a   






















Fig. (3). IFN-  production in mixed and transwell cultures of 
DO11.10 CD4+ T cells and elicited peritoneal macrophages. T cells 
and macrophages were co-cultured or cultured in transwell. Perito-
neal macrophages were isolated and cultured in the presence of 
medium alone or viable Salmonella. Following exposure for 45 
minutes, cells were washed to remove any extracellular bacteria 
with gentamicin-containing medium. Magnetically separated 
splenic DO11.10 CD4 + T cells, B cells, and OVA peptide were co-
cultured or separated by transwells (A). To evaluate the role of IL-
12, some mixed cultures were supplemented with anti-IL-12p40 
antibody or isotype control antibody (B). Levels of IFN- in 48-
hour supernatants were measured by enzyme immunoassay, and are 
reported as mean values of triplicate determinations. These studies 
were performed three times with similar results. 
  To determine the nature of this soluble stimulation, anti-
IL-12 antibodies were added to cultures (Fig. 3B). While 
IFN- levels were unperturbed by addition of isotype control 
antibody, reductions were observed in those cultures treated 
with anti-IL-12 (Fig. 3B). Taken together, the studies pre-
sented demonstrate the relative contributions of both cellular 
contact and IL-12 in the activation of antigen-specific IFN- 
production. 
COX-2 Activity Influences IFN- Production in Antigen 
Stimulated Cultures of DO11.10 CD4+ T Cells 
  We next questioned whether Celecoxib could inhibit 
IFN- production in antigen stimulated cultures of CD4+ T 
cells. To address this question, DO11.10 CD4+ T cells and B 
cells, stimulated with Ova peptide, were incubated with   
untreated (Fig. 4A) or cultured with Salmonella-infected 
macrophages (Fig. 4B). In addition, some cultures were 
treated with 1 uM celecoxib to hinder COX-2 activity. IFN- 
levels are augmented by the addition of celecoxib in both 






























Fig. (4). COX-2 activity influences IFN- and IL-12p70 production 
in antigen stimulated cultures of DO11.10 CD4+ T cells. Peritoneal 
macrophages were isolated and cultured in the presence of medium 
alone (A) or viable Salmonella  (B). Following exposure for 45 
minutes, cells were washed to remove any extracellular bacteria 
with gentamicin-containing medium. Magnetically separated 
splenic DO11.10 CD4 + T cells, B cells, and OVA peptide were 
added. To assess the role of COX-2, some cultures were supple-
mented with 1 uM celecoxib 20 minutes prior to infection. Levels 
of IFN- (A and B) and IL-12p70 (C) in 48-hour supernatants were 
measured by enzyme immunoassay, and are reported as mean val-
ues of triplicate determinations. These studies were performed three 
times with similar results. 
  Analysis of supernatants from mixed cultures of macro-
phages and DO11.10 CD4+ T and B cells revealed that in-
fection with Salmonella does elicit in vitro production of IL-Celecoxib Treatment Augments Interferon Gamma In Vitro  The Open Microbiology Journal, 2009, Volume 3    27 
12p70 (Fig. 4C). Inhibition of COX-2 with celecoxib   
treatment further increased IL-12 secretion, indicating that 
the endogenous PGE2 synthesis resulting from infection can 
reduce the IL-12 response (Fig. 4C). 
COX-2 Activity Influences IFN- Production in Cultures 
Exposed to Recombinant IL-12 
  We next questioned whether treatment with celecoxib 
could alter IL-12-induced IFN- secretion in co-cultures   
of CD4+ T cells and macrophages. Fig. (5A) demonstrates 
that IL-12-induced IFN- production was significantly   
increased in the presence of celecoxib. More importantly, in 
Salmonella infected cultures, a significant increase in IFN- 
production was also observed with celecoxib treatment.   
Collectively, these results support the notion that COX-2 























Fig. (5). COX-2 activity influences IFN-  production in IL-12 
stimulated cultures of BALB/c CD4+ T cells. IFN- production   
by CD4 + T cells in the presence or absence of celecoxib was 
evaluated. Peritoneal macrophages were isolated and cultured in the 
presence of medium alone (A) or viable Salmonella (B). Following 
exposure for 45 minutes, cells were washed to remove any extracel-
lular bacteria with gentamicin-containing medium. Magnetically 
separated splenic BALB/c CD4 + T cells were added and cultured 
in the presence of IL-12 and/or celecoxib. Results are presented   
as mean values of triplicate determinations. These studies were 
performed twice with similar results. 
DISCUSSION 
  We have previously demonstrated a surprising potential 
for induction of PGE2 synthesis upon infection with Salmo-
nella typhimurium both in cultured immune cells and   
lymphoid tissue [21]. High levels of PGE2 can be inhibitory 
for T cell-mediated immunity, a vital component of the host 
defense against Salmonella. The fact that PGE2 production 
occurs in the mesenteric lymph nodes demonstrates the pres-
ence of increased prostaglandins at mucosal sites following 
infection, and suggests that these mediators are present to 
influence the developing host response [21].  
  In the current study we began to address the impact   
of COX-2 activation and PGE2 production on IFN- produc-
tion using co-cultures of antigen-specific CD4+ T lympho-
cytes and Salmonella-infected macrophages and dendritic 
cells. When DO11.10 CD4+ T cells are co-cultured with 
Salmonella-infected macrophages, they are exposed to   
elevated amounts of PGE2 (Fig. 1B). This in vitro result 
seems to mimic what occurs in vivo [21]. Salmonella-
infected macrophages (Fig. 2A), or dendritic cells (Fig. 2B), 
augment the production of IFN- by DO11.10 CD4+ T cells 
in the presence of antigen. This antigen-stimulated IFN- 
production in macrophage-infected cultures is enhanced   
by cell/cell contact (Fig. 3A) or by IL-12 produced in these 
co-cultures (Fig. 3B). The presence of celecoxib signifi-
cantly elevates the levels of IFN- (Figs. 4A and 4B) and  
IL-12p70 (Fig. 4C) produced in these antigen-stimulated   
co-cultures. Taken together these in vitro studies demon-
strate that blocking COX-2 activity can significantly increase 
mediators (i.e. IFN- and IL-12) which augment T helper 
type 1 responses [3-7]. 
 If  these  in vitro studies accurately depict what occurs   
in vivo following Salmonella infection, then they may have 
important implications for this bacterial infection being able 
to limit a protective T helper type 1 response. The ability of 
Salmonella infection to induce the production of PGE2  
in vivo [21] and in vitro (Fig. 1) likely serves to limit a   
T helper type 1 response [14-18]. While this response could 
be beneficial to the host by limiting a destructive,   
pro-inflammatory response, it may also limit the T helper 
type 1 response below what would be optimal for the   
immune response against this intracellular pathogen.   
Evidence to support this possibility comes from our previous 
work demonstrating that therapeutic administration of IL-12 
can augment the protective host response against Salmonella 
[13]. The implication of this finding is that the host does   
not produce sufficient amounts of this cytokine to initiate   
a protective T helper type 1 response. The present work   
suggests that one mechanism which may be responsible for 
limiting IL-12 initiated IFN- is the presence of PGE2  
induced by Salmonella. Future studies will be necessary to 
determine if treatment with COX-2 inhibitors can augment 
the protective T helper type 1 response against Salmonella in 
animal models. 
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